Skip to main
IQV
IQV logo

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 47%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

The positive outlook for IQVIA Holdings is supported by robust growth in its Flexible Solutions Provider (FSP), Real World Evidence (RWE), and Clinical Trial Management System (CSMS) segments, which exhibited year-over-year increases in Q3. The company has demonstrated resilience in its commercial operations, bolstered by improved client decision timelines and a strong pipeline related to recent drug launches, contributing to a low-teens year-over-year increase in Request for Proposals (RFP) flow. Additionally, IQVIA's pricing environment has improved, allowing the company to turn down less favorable deals, while R&D Services (R&DS) is projected to achieve a growth rate exceeding 4% on a constant currency basis, excluding COVID-19 impacts.

Bears say

The financial analysis reveals several fundamental issues contributing to a negative outlook for IQVIA Holdings's stock. Year-over-year constant currency growth has declined to 3.8%, down from 6.8% in the previous quarter, indicating a weakening growth trajectory that may not meet management's expectations for 2026, which they deemed disappointing if growth falls below 5%. Additionally, challenges such as difficult year-over-year comparisons, concerns over potential revenue growth slowdowns in real-world evidence (RWE), and margin pressure from passthroughs further exacerbate the company's financial vulnerabilities, compounded by the impact of rising interest rates on earnings.

IQVIA Hlds (IQV) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 47% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 17 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Nov 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $242.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $242.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.